Advisory Board and Editors Rheumatology

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Linda S Ehrlich-Jones

Dr. Linda Ehrlich-Jones works in the Center for Rehabilitation Outcomes Research. She has been involved in creation of behavioral interventions, using motivational interviewing, targeting persons with chronic illness to increase physical activity and improve diet. She oversees the Rehabilitation Measures Database, a compendium of summaries of instruments utilized by rehabilitation professionals. Her faculty appointments at Northwestern University Feinberg School of Medicine include Physical Medicine & Rehabilitation and the Institute for Public Health and Medicine.

Past-President Association of Rheumatology Health Professionals
Recipient of the Addie Thomas Service Award (Association of Rheumatology Health Professionals, 2014)

James Harris

Group Leader in Arthritis and Lupus Research Group, Department of Medicine, Monash University. Interests in cytokine biology, inflammasomes, MIF, autophagy, inflammation, innate immunity, veterinary and comparative immunology.
Deputy Editor, Immunology and Cell Biology.
Review Editor, Frontiers in Immunology.
Editorial Board member, Arthritis Research & Therapy.

Md Asiful Islam

Dr Asiful is currently working as a research fellow at the WHO Collaborating Centre for Global Women’s Health, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, UK.

Dr Md Asiful Islam completed his PhD (Fast Track, Passed with Grade 1, Pass without correction) in Genetics & Autoimmunity from Human Genome Centre, Universiti Sains Malaysia (November 2018) under Professor Dr Siew Hua Gan following completing BSc in Biochemistry & Molecular Biology (Jahangirnagar University, Dhaka, Bangladesh). He achieved Malaysia International Scholarship and USM Vice-Chancellor Award during his PhD and working as a Senior Lecturer at the Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia from 2019 till 2022.

Besides PeerJ, he has been working as an Academic Editor for Nature Scientific Data, PLOS ONE, BMC Rheumatology, Autoimmunity Highlights, Endocrine, Metabolic & Immune Disorders - Drug Targets, Current Immunology Reviews and Current Rheumatology Reviews.

Dr Asiful's research interest covers different research areas of Medical Sciences including Haematology, Immunology, Pharmacology, Molecular Genetics and Neurosciences. He is currently focused on developing and executing systematic reviews and meta-analyses decoding various research questions of Medical Sciences.

Jorge Kalil

Jorge Kalil is Professor of Clinical Immunology and Allergy and Director of the Laboratory of Immunology at the Heart Institute (InCor), School of Medicine, University of São Paulo (FMUSP), Brazil. He is Adjunct Professor at the George Washington University, DC, USA, and at the Case Westen University, Cleveland. He represents Latin America in the scientific advisory board of the International Institute of Genetic Engineering and Biotechnology (ICGEB), an UNO Institution since 2013 and a member of the Brazilian Academy of Sciences since 1995. Since 2001, he coordinates iii-Institute for Investigative Immunology, a National Institute linked to the Ministry of Science and Technology, in Brazil. In addition, he co-chairs the Federation of Clinical Immunology Societies - FOCIS Center of Excellence in São Paulo and member of the Council of the USP Pasteur Institute’s board since 2018. He is member of the DSMB/NIH for analyses of phase 3 clinical trials of vaccines anti COVID supported by the US government and board member of COVAX, a WHO/GAVI/CEPI initiative to selecting and buying COVID vaccines to distribute to the world. Kalil graduated in Medicine in Brazil (1977), has a Master’s degree in Immunology and Immunogenetics and is Doctor of Science in Human Biology. He is currently developing vaccines against COVID-19 Streptococcus, HIV, Dengue and Zika in advanced scientific stage.

Elizabeth G. Laird

My research goals are to characterise the mechanisms of collagenous tissue development, repair and renewal. Current research interests include understanding the dynamics of collagen synthesis and turnover, the role of stem cells in musculoskeletal homeostasis and the role of glucose in musculoskeletal ageing. Tissues of interest are primarily tendon and ligament but include cartilage, bone, cornea and intervertebral disc, as well as fibrotic tissue.

This research is important because age-related degeneration and loss of function in musculoskeletal tissues is associated with chronic joint pain, limited movement, tendinopathy, ligament damage, intervertebral disc degeneration and osteoarthritis. There is both a loss of tissue integrity and propensity to fibrosis indicating that homeostasis of the collagenous extracellular matrix is lost with age. Understanding the molecular processes that create functional musculoskeletal tissues during development and growth, and which malfunction or cease to operate in aged tissues is key to developing new strategies for tissue engineering, to activate intrinsic stem cell repair mechanisms and to develop beneficial pharmaceutical, dietary or exercise-based interventions in an increasingly aged society.

G Lorimer Moseley

Professor of Clinical Neurosciences & Foundation Chair in Physiotherapy, Director of Innovation in Implementation and Clinical Translation (IIMPACT) Research Collaboration at the University of South Australia; Fellow of the Australian Academy of Health & Medical Science; Hon Fellow, Faculty of Pain Medicine, Australia New Zealand College of Anaesthetists; Fellow, Australian College of Physiotherapists & Honoured Member, Australian Physiotherapy Association; Principal Research Fellow, National Health & Medical Research Council of Australia.

Tuan V. Nguyen

Dr. Nguyen is Distinguished Professor of Predictive Medicine at the School of Biomedical Engineering, University of Technology Sydney (Australia). He also holds joint appointments as Professor, St Vincent's Clinical School, University of New South Wales (UNSW Sydney); and adjunct Professor of Epidemiology and Biostatistics at the School of Medicine, University of Notre Dame Australia.

Feng Pan

Dr. Pan is a Senior Research Fellow at Menzies Institute for Medical Research. He has been researching both epidemiology and clinical interventions to osteoarthritis-related pain. Much of his work has been on identifying biomechanical risk factors for chronic pain and osteoarthritis, identifying pain and osteoarthritis phenotypes and testing new therapeutic treatments.

Angela Rösen-Wolff

Study of Medicine at the Ruprecht-Karls-Universiy in Heidelberg, Germany; Habilitation in Experimental Virology. Head of Clinical Research at the Department of Pediatrics, University Hospital Carl Gustav Carus at TU Dresden, Germany, since 1995. Speaker of Clinical Research Unit 249 "Defects of the Innate Immune System in Autoinflammation and Autoimmunity" since 2010

Anita E Wluka

Anita is an Associate Professor in the School of Public Health and Preventive Medicine, Monash University, and a Clinical Rheumatologist, Alfred Hospital, Melbourne.

Recognised as a world-leader in osteoarthritis research, Anita is based at The Alfred hospital where she combines research with clinical practice as a physician. Her work has contributed to guidelines for managing hip and knee osteoarthritis developed through the Royal Australasian College of General Practitioners National Health and Medical Research Council.